Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2024 Mar;322(1):138-147.
doi: 10.1111/imr.13310. Epub 2024 Jan 29.

Severe combined immunodeficiency diagnosis and genetic defects

Carolina Sanchez Aranda  1 , Mariana Pimentel Gouveia-Pereira  1 , Celso Jose Mendanha da Silva  1 , Maria Candida Faria Varanda Rizzo  1 , Edson Ishizuka  2 , Edgar Borges de Oliveira  2 , Antonio Condino-Neto  3
Affiliations
Review

Severe combined immunodeficiency diagnosis and genetic defects

Carolina Sanchez Aranda et al. Immunol Rev. 2024 Mar.

Abstract

Severe combined immunodeficiency (SCID) is a rare and life-threatening genetic disorder that severely impairs the immune system's ability to defend the body against infections. Often referred to as the "bubble boy" disease, SCID gained widespread recognition due to the case of David Vetter, a young boy who lived in a sterile plastic bubble to protect him from germs. SCID is typically present at birth, and it results from genetic mutations that affect the development and function of immune cells, particularly T cells and B cells. These immune cells are essential for identifying and fighting off infections caused by viruses, bacteria, and fungi. In SCID patients, the immune system is virtually non-existent, leaving them highly susceptible to recurrent, severe infections. There are several forms of SCID, with varying degrees of severity, but all share common features. Newborns with SCID often exhibit symptoms such as chronic diarrhea, thrush, skin rashes, and persistent infections that do not respond to standard treatments. Without prompt diagnosis and intervention, SCID can lead to life-threatening complications and a high risk of mortality. There are over 20 possible affected genes. Treatment options for SCID primarily involve immune reconstitution, with the most well-known approach being hematopoietic stem cell transplantation (HSCT). Alternatively, gene therapy is also available for some forms of SCID. Once treated successfully, SCID patients can lead relatively normal lives, but they may still require vigilant infection control measures and lifelong medical follow-up to manage potential complications. In conclusion, severe combined immunodeficiency is a rare but life-threatening genetic disorder that severely compromises the immune system's function, rendering affected individuals highly vulnerable to infections. Early diagnosis and appropriate treatment are fundamental. With this respect, newborn screening is progressively and dramatically improving the prognosis of SCID.

Keywords: SCID; child; diagnosis; genetics; immunodeficiency.

PubMed Disclaimer

References

REFERENCES

    1. Abolhassani H, Azizi G, Sharifi L, et al. Global systematic review of primary immunodeficiency registries. Expert Rev Clin Immunol. 2020;16:717-732.
    1. Bousfiha AA, Jeddane L, Ailal F, et al. Primary immunodefciency diseases worldwide: more common than generally thought. J Clin Immunol. 2013;33:1-7.
    1. Bousfiha A, Moundir A, Tangye SG, et al. The 2022 update of IUIS phenotypical classification for human inborn errors of immunity. J Clin Immunol. 2022;42(7):1508-1520.
    1. Perez EE, Orange JS, Bonilla F, et al. Update on the use of immunoglobulin in human disease: a review of evidence. J Allergy Clin Immunol. 2017;139(3S):S1-S46.
    1. Soshnick SH, Joseph T, Bennett NJ. Humoral immunodeficiency and immune globulin replacement therapy (IGRT) usage in DiGeorge syndrome. J Clin Immunol. 2021;41(6):1208-1212.

Publication types

Supplementary concepts

LinkOut - more resources